Skip to main content
Karuna Ganesh, MD, Oncology, New York, NY

KarunaGaneshMDPhD

Oncology New York, NY

Hematologic Oncology

Assistant Member, Molecular Pharmacology Program and GI Oncology Service, Director of Metastasis Research, Center for Colorectal Cancer, Memorial Sloan Kettering Cancer Center, Assistant Professor, Weill Cornell Medical College

Overview of Dr. Ganesh

Dr. Karuna Ganesh is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from School of Clinical Medicine, University of Cambridge and has been in practice 7 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 40 publications and over 500 citings.

Education & Training

  • University of Cambridge School of Medicine
    University of Cambridge School of MedicineClass of 2010
  • School of Clinical Medicine, University of Cambridge
    School of Clinical Medicine, University of CambridgeClass of 2010
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2015 - 2026
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • MA State Medical License
    MA State Medical License 2011 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • The Gut Microbiome and Cancer: MSK Researchers Present New Findings
    The Gut Microbiome and Cancer: MSK Researchers Present New FindingsApril 19th, 2023
  • Memorial Sloan Kettering Scientists Identify Potential New Strategy Against Metastasis
    Memorial Sloan Kettering Scientists Identify Potential New Strategy Against MetastasisMarch 29th, 2023
  • The Pershing Square Sohn Cancer Research Alliance Awards $4.2M to Seven Emerging Trailblazers in Cancer Research
    The Pershing Square Sohn Cancer Research Alliance Awards $4.2M to Seven Emerging Trailblazers in Cancer ResearchJune 7th, 2022
  • Join now to see all